{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T23:15:44Z","timestamp":1720566944244},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jocn-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jocn.2018.12.034","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T22:10:22Z","timestamp":1546553422000},"page":"226-228","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Remarkable improvement in progressive multifocal leukoencephalopathy following acute pyelonephritis with bacteremia"],"prefix":"10.1016","volume":"62","author":[{"given":"Eiichiro","family":"Amano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kokoro","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Sanjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2018.12.034_b0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11908-016-0543-8","article-title":"Progressive multifocal leukoencephalopathy in HIV-uninfected individuals","volume":"18","author":"Saylor","year":"2016","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.jocn.2018.12.034_b0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fimmu.2015.00159","article-title":"Immune system involvement in the pathogenesis of JC virus induced PML: what is learned from studies of patients with underlying diseases and therapies as risk factors","volume":"6","author":"Monaco","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jocn.2018.12.034_b0015","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.24371","article-title":"Persistence and pathogenesis of the neurotropic polyomavirus JC","volume":"77","author":"Wollebo","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2018.12.034_b0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s13365-013-0173-y","article-title":"A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes","volume":"19","author":"Clifford","year":"2013","journal-title":"J Neurovirol"},{"key":"10.1016\/j.jocn.2018.12.034_b0025","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archneurol.2008.557","article-title":"Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy","volume":"66","author":"Cettomai","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2018.12.034_b0030","doi-asserted-by":"crossref","first-page":"A404","DOI":"10.1016\/j.autrev.2011.12.001","article-title":"IgM predominance in autoimmune disease: genetics and gender","author":"Duarte-Rey","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jocn.2018.12.034_b0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/WNL.52.2.253","article-title":"JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy","volume":"52","author":"Koralnik","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2018.12.034_b0040","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1128\/JVI.02565-14","article-title":"JC virus quasispecies analysis reveals a complex viral population underlying progressive multifocal leukoencephalopathy and supports viral dissemination via the hematogenous route","volume":"89","author":"Van","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.jocn.2018.12.034_b0045","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00467-013-2513-9","article-title":"The innate immune response during urinary tract infection and pyelonephritis","volume":"29","author":"Spencer","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jocn.2018.12.034_b0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1756285615602832","article-title":"Progressive Multifocal Leukoencephalopathy Consortium. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives","volume":"8","author":"Pavlovic","year":"2015","journal-title":"Ther Adv Neurol Disord"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586818319386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586818319386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T22:39:54Z","timestamp":1552430394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586818319386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":10,"alternative-id":["S0967586818319386"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2018.12.034","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remarkable improvement in progressive multifocal leukoencephalopathy following acute pyelonephritis with bacteremia","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2018.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}